加兰他敏作为尼古丁成瘾的治疗选择。

IF 1.2 Q4 SUBSTANCE ABUSE
Journal of Smoking Cessation Pub Date : 2021-07-17 eCollection Date: 2021-01-01 DOI:10.1155/2021/9975811
Qutub Jamali
{"title":"加兰他敏作为尼古丁成瘾的治疗选择。","authors":"Qutub Jamali","doi":"10.1155/2021/9975811","DOIUrl":null,"url":null,"abstract":"<p><p>The pharmacological therapy for smoking cessation recommended by National Institute for Health and care Excellence (NICE) guidelines is nicotine replacement therapy such as gum, inhalator, lozenge, nasal spray, oral spray, sublingual tablet, and transdermal patch. Medications such as bupropion and varenicline are also used. Varenicline is the only established drug used to alleviate symptoms of craving as it acts as a partial nicotine agonist. Galantamine has a similar mechanism of action where it is an acetylcholinesterase inhibitor and nicotinic receptor agonist. However, varenicline is the only recommended drug. There are not many studies to illustrate the effectiveness of galantamine for smoking cessation. This article explores the possibility of potential use of galantamine in alleviating the symptoms of nicotine withdrawal.</p>","PeriodicalId":39350,"journal":{"name":"Journal of Smoking Cessation","volume":" ","pages":"9975811"},"PeriodicalIF":1.2000,"publicationDate":"2021-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313356/pdf/","citationCount":"4","resultStr":"{\"title\":\"Galantamine as a Treatment Option for Nicotine Addiction.\",\"authors\":\"Qutub Jamali\",\"doi\":\"10.1155/2021/9975811\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The pharmacological therapy for smoking cessation recommended by National Institute for Health and care Excellence (NICE) guidelines is nicotine replacement therapy such as gum, inhalator, lozenge, nasal spray, oral spray, sublingual tablet, and transdermal patch. Medications such as bupropion and varenicline are also used. Varenicline is the only established drug used to alleviate symptoms of craving as it acts as a partial nicotine agonist. Galantamine has a similar mechanism of action where it is an acetylcholinesterase inhibitor and nicotinic receptor agonist. However, varenicline is the only recommended drug. There are not many studies to illustrate the effectiveness of galantamine for smoking cessation. This article explores the possibility of potential use of galantamine in alleviating the symptoms of nicotine withdrawal.</p>\",\"PeriodicalId\":39350,\"journal\":{\"name\":\"Journal of Smoking Cessation\",\"volume\":\" \",\"pages\":\"9975811\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2021-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313356/pdf/\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Smoking Cessation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2021/9975811\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Smoking Cessation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/9975811","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 4

摘要

国家健康与护理卓越研究所(NICE)指南推荐的戒烟药物治疗是尼古丁替代疗法,如口香糖、吸入器、含片、鼻喷雾剂、口服喷雾剂、舌下片剂和透皮贴剂。也可以使用安非他酮和伐尼克兰等药物。伐尼克兰是唯一一种用于缓解渴望症状的药物,因为它是部分尼古丁激动剂。加兰他敏具有类似的作用机制,它是乙酰胆碱酯酶抑制剂和烟碱受体激动剂。然而,伐尼克兰是唯一推荐的药物。没有太多的研究来说明加兰他明对戒烟的有效性。本文探讨了加兰他敏在缓解尼古丁戒断症状中的潜在应用的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Galantamine as a Treatment Option for Nicotine Addiction.

The pharmacological therapy for smoking cessation recommended by National Institute for Health and care Excellence (NICE) guidelines is nicotine replacement therapy such as gum, inhalator, lozenge, nasal spray, oral spray, sublingual tablet, and transdermal patch. Medications such as bupropion and varenicline are also used. Varenicline is the only established drug used to alleviate symptoms of craving as it acts as a partial nicotine agonist. Galantamine has a similar mechanism of action where it is an acetylcholinesterase inhibitor and nicotinic receptor agonist. However, varenicline is the only recommended drug. There are not many studies to illustrate the effectiveness of galantamine for smoking cessation. This article explores the possibility of potential use of galantamine in alleviating the symptoms of nicotine withdrawal.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Smoking Cessation
Journal of Smoking Cessation Medicine-Psychiatry and Mental Health
CiteScore
1.70
自引率
0.00%
发文量
13
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信